Lyell CSO: New job is 'the missing piece' of his career; Orphazyme and Cortexyme and Sio, oh my: Your guide to the latest CEO changes
“I fully recognize that cell therapy is still all about the cells.”
In moving over to his second CSO job, Gary Lee says he …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
